For instance, in luminal breast cancer, SERD development has benefited significantly from docking, VS, and MD simulations applied to ESR1 mutations [48,49,50,51,52,53,54,55,56,57,58,59]. The gene discussed is ESR1; the disease is breast carcinoma.